Divisions of Clinical Epidemiology, Rheumatology and Respiratory Epidemiology and Clinical Trials Unit, McGill University, Center for Outcomes Research, Montreal, QC, Canada.
Division of Rheumatology, Department of Medicine, Johns Hopkins University.
Rheumatology (Oxford). 2020 Jul 1;59(7):1662-1670. doi: 10.1093/rheumatology/kez506.
To evaluate the impact of integrating patient-reported outcomes (PROs) into routine clinics, from the perspective of patients with RA, clinicians and other staff.
We conducted a prospective cohort study using a mixed methods sequential explanatory design at an academic arthritis clinic. RA patients completed selected Patient-Reported Outcomes Measurement Information System measures on tablets in the waiting room. Results were immediately available to discuss during the visit. Post-visit surveys with patients and physicians evaluated topics discussed and their impact on decision making; patients rated confidence in treatment. Focus groups or interviews with patients, treating rheumatologists and clinic staff were conducted to understand perspectives and experiences.
Some 196 patients and 20 rheumatologists completed post-visit surveys at 816 and 806 visits, respectively. Focus groups were conducted with 24 patients, 10 rheumatologists and 4 research/clinic staff. PROs influenced medical decision-making and RA treatment changes (38 and 18% of visits, respectively). Patients reported very high satisfaction and treatment confidence. Impact on clinical workflow was minimal after a period of initial adjustment. PROs were valued by patients and physicians, and provided new insight into how patients felt and functioned over time. Reviewing results together improved communication, and facilitated patient-centred care, shared decision making, and the identification of new symptoms and contributing psychosocial/behavioural factors.
PRO use at RA visits was feasible, increased understanding of how disease affects how patients feel and function, facilitated shared decision-making, and was associated with high patient satisfaction and treatment confidence.
从类风湿关节炎(RA)患者、临床医生和其他工作人员的角度,评估将患者报告结局(PROs)纳入常规临床实践的影响。
我们在一家学术关节炎诊所进行了一项前瞻性队列研究,采用混合方法序贯解释设计。RA 患者在候诊室使用平板电脑完成特定的患者报告结局测量信息系统量表。就诊期间可立即获得结果并进行讨论。就诊后,患者和医生完成问卷调查,评估讨论的主题及其对决策的影响;患者评价对治疗的信心。对患者、治疗风湿科医生和诊所工作人员进行焦点小组或访谈,以了解观点和经验。
在 816 次就诊中有 196 名患者和 20 名风湿科医生完成了就诊后问卷调查,在 806 次就诊中有 196 名患者和 20 名风湿科医生完成了就诊后问卷调查。进行了 24 名患者、10 名风湿科医生和 4 名研究/诊所工作人员的焦点小组。PROs 影响医疗决策和 RA 治疗改变(分别为 38%和 18%的就诊)。患者报告非常高的满意度和治疗信心。经过一段时间的初步调整,对临床工作流程的影响最小。PROs 受到患者和医生的重视,并提供了有关患者随时间感觉和功能的新见解。共同审查结果改善了沟通,促进了以患者为中心的护理、共同决策以及识别新症状和相关心理社会/行为因素。
在 RA 就诊时使用 PRO 是可行的,增加了对疾病如何影响患者感觉和功能的理解,促进了共同决策,并与患者满意度和治疗信心高相关。